191 related articles for article (PubMed ID: 3187844)
1. [In-vitro change in CFU-GM in chronic myeloid leukemia and myelodysplastic syndromes. Its implication in the dysfunction of the hematologic barrier].
Gronda M; Malka A; Demattei A; Elizalde P; Santarelli MT; Bianchi de Di Risio CC
Sangre (Barc); 1988 Aug; 33(4):277-81. PubMed ID: 3187844
[No Abstract] [Full Text] [Related]
2. [Analysis of chronic myeloproliferative syndromes using the technics of in vitro hematopoiesis (the origin and function of marrow stromal cells in CML)].
Takahashi M; Fujiwara M
Rinsho Ketsueki; 1988 Jul; 29(7):994-1000. PubMed ID: 3184486
[No Abstract] [Full Text] [Related]
3. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
[TBL] [Abstract][Full Text] [Related]
5. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
[TBL] [Abstract][Full Text] [Related]
6. [Proliferative activity of granulocyte progenitors from the bone marrow of patients with chronic myeloid leukemia in 14-day culture in vivo].
Hansz J; Kozłowska-Skrzypczak M
Acta Haematol Pol; 1989; 20(1):29-35. PubMed ID: 2618564
[TBL] [Abstract][Full Text] [Related]
7. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
[TBL] [Abstract][Full Text] [Related]
8. [Biology and clinical aspects of primary myelodysplastic syndromes].
Urbańska-Ryś H; Robak T; Krykowski E
Pol Tyg Lek; 1988 Feb; 43(7):225-9. PubMed ID: 3043403
[No Abstract] [Full Text] [Related]
9. Hematon: a multicellular functional unit in primary hematopoiesis.
Blazsek I; Misset JL; Comisso M; Mathé G
Biomed Pharmacother; 1988; 42(10):661-8. PubMed ID: 3266080
[TBL] [Abstract][Full Text] [Related]
10. Studies on CFU-mix of 47 patients with leukemia and myelodysplastic syndrome.
Chen Y; Wang BM; Li CY; Yu DJ
Chin Med J (Engl); 1989 Jun; 102(6):425-30. PubMed ID: 2512062
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.
Tennant GB; Jacobs A; Bailey-Wood R
Exp Hematol; 1986 Dec; 14(11):1063-8. PubMed ID: 3780888
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
[TBL] [Abstract][Full Text] [Related]
13. Competitive repopulation in leukemic and normal bone marrow.
Brecher G; Pallavicini MG; Cronkite EP
Blood Cells; 1993; 19(3):691-7; discussion 698-707. PubMed ID: 8018950
[TBL] [Abstract][Full Text] [Related]
14. The influence of amifostine used alone or in combination with 2-chlorodeoxyadenosine on normal and chronic myelogenous leukemia granulocyte-macrophage progenitor cells in vitro.
Korycka A; Robak T
Arch Immunol Ther Exp (Warsz); 2000; 48(4):293-9. PubMed ID: 11059647
[TBL] [Abstract][Full Text] [Related]
15. Mobilization of hematopoietic progenitors in patients with chronic myeloid leukemia.
Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; Niewint AW; Ossenkoppele GJ
Bone Marrow Transplant; 1997 Nov; 20(10):835-42. PubMed ID: 9404923
[TBL] [Abstract][Full Text] [Related]
16. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes.
Rosati S; Anastasi J; Vardiman J
Semin Hematol; 1996 Apr; 33(2):111-26. PubMed ID: 8722682
[No Abstract] [Full Text] [Related]
17. Stem cell origin of human myeloid blood cell neoplasms.
Fialkow PJ
Verh Dtsch Ges Pathol; 1990; 74():43-7. PubMed ID: 1708632
[TBL] [Abstract][Full Text] [Related]
18. [Results of selected cytochemical studies of mature granulocytes in myelodysplastic syndromes and various other hematologic diseases].
Mariańska B; Apel D; Maj S
Acta Haematol Pol; 1991; 22(1):54-7. PubMed ID: 1823968
[TBL] [Abstract][Full Text] [Related]
19. Difficulties in collecting peripheral blood stem cells in chronic myeloid leukemia related to persistence of the leukemic cell clone.
Hénon PR; Eisenmann JC; Becker M; Beck-Wirth G; Wunder E; Sovalat H
Stem Cells; 1993 Oct; 11 Suppl 3():43-7. PubMed ID: 8298478
[TBL] [Abstract][Full Text] [Related]
20. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes].
García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F
Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
